Preparing for the Veeva CRM Platform Transition

Home › Blog › Veeva CRM Transition Planning
Salesforce CRM for Life Sciences with AI, compliance, and patient engagement
Status as of October 2026: In its August 28, 2023 announcement, Veeva stated that Veeva CRM will be supported until the end of December 2029. Confirm the current dates with Veeva before making program decisions. Source: Veeva press release.

Organizations running Veeva CRM on Salesforce should use the transition period to evaluate future platform, data, integration, AI and operating-model choices well before a mandatory deadline drives the program.

Six decisions to make early

Platform strategy

Veeva Vault CRM versus Salesforce Life Sciences Cloud. See our comparison guide.

Data strategy

Where HCP/HCO and engagement data should be mastered and activated.

AI strategy

How CRM participates in enterprise AI and governance.

Integration strategy

Which interfaces can be retained, remapped or modernized.

Commercial & medical operating model

How users should work in the future platform.

Total cost

Licenses, implementation, migration, integration, validation, training and ongoing operations.

A practical sequence

01

Assess

Understand the current environment and its dependencies.

02

Decide

Choose the platform with clear criteria.

03

Plan

Sequence countries, business units and waves.

04

Execute

Migrate with rehearsals and controlled cutover.

Starting early leaves room for rehearsals, phased rollouts and adoption work instead of compressing them against a deadline. When you’re ready, our Veeva to Salesforce migration services and readiness assessment can help.

Schedule a CRM Transition Strategy Session

Work through platform, data, integration and AI choices with a Cendance architect.

Latest Articles